See also this year's filing and all EDGAR filings for this company.
PDF Report 0001402785_2013_Fluoropharma_Medical_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.00031126514827736903, 'aggregate_val': 4149510, 'exp_sum': 4150802, 'exp_to_value': {'GeneralAndAdministrativeExpense': 1549591, 'ResearchAndDevelopmentExpense': 1423286, 'remainder_Expenses': 1177925}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001402785')"} |
Graph
Absolute values for 0001402785, Fluoropharma Medical INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 235,507 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 1,381,398 |
| 4 | AssetsNoncurrent | 0 |
| 5 | PropertyPlantAndEquipmentNet | 176,889 |
| 6 | Goodwill | 55,247 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 1,549,591 |
| 9 | ResearchAndDevelopmentExpense | 1,423,286 |
| 10 | remainder_Expenses | 1,176,633 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -35,181 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 235,507 |
| 1 | Assets | 1,613,534 |
| 2 | Expenses | 4,149,510 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,378,027 |
| 5 | NetIncome | -4,184,691 |
| 6 | ComprehensiveNetIncome | -4,184,691 |
| 7 | BaseVar | 3,016,866 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.48 |
| 9 | EconomicCapitalRatio | 0.215 |
Edgar->Model Mapping
Feature Distribution
Change over Time
